Successful pediatric living donor liver transplantation from carrier to carrier of hereditary butyrylcholinesterase variant

Pediatric Transplantation

Volumn 11, Issue 6, 2007, Pages 694-697

  Kawano, Youichi ^a   Mizuta, Koichi ^a   Hisikawa, Shuji ^a   Saito, Takeshi ^a   Egami, Satoshi ^a   Takatsuka, Yuka ^a   Sanada, Yukihiro ^a   Fujiwara, Takehito ^a   Yasuda, Yoshikazu ^a   Ohmori, Masami ^a   Sakamoto, Koichi ^a   Liu, Weidong ^b   Nishiguchi, Shuhei ^b   Hada, Toshikazu ^b   Kawarasaki, Hideo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

DNA sequencing; Hereditary butyrylcholinesterase (BChE) variant; Hypocholinesterasemia; Living donor liver transplantation; Pediatric liver transplantation

Indexed keywords

CHOLINESTERASE; FRESH FROZEN PLASMA; IMMUNOSUPPRESSIVE AGENT; STEROID;

ARTICLE; BILE DUCT ATRESIA; BLOOD EXAMINATION; CASE REPORT; DNA SEQUENCE; DRUG PULSE THERAPY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GRAFT REJECTION; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; OXYGENATION; PALLIATIVE THERAPY; PORTOENTEROSTOMY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; RECIPIENT; VIRUS INFECTION;

BUTYRYLCHOLINESTERASE; FEMALE; HETEROZYGOTE; HUMANS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS;

EID: 34547475488     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00750.x     Document Type: Article

References (21)

1. Matsuzaki S, Onda M, Tajiri T, Kim DY. Hepatic lobar differences in progression of chronic liver disease: Correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology 1997 : 25 : 828 832.
2. Viby-Mogensen J, Hanel HK. Prolonged apnoea after suxamethonium: An analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1978 : 22 : 371 380.
3. Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 1990 : 47 : 35 60.
4. Barta C, Sasvari-Szekely M, Devai A, Kovacs E, Staub M, Enyedi P. Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia. Mol Genet Metab 2001 : 74 : 484 488.
5. Khoury GF, Brill J, Walts L, Busuttil RW. A typical serum cholinesterase eliminated by orthotopic liver transplantation. Anesthesiology 1987 : 67 : 273 274.
6. Sockalingam I, Green DW. Mivacurium-induced prolonged neuromuscular block. Br J Anaesth 1995 : 74 : 234 236.
7. Liu W, Cheng J, Iwasaki A, Imanishi H, Hada T. Novel mutation and multiple mutations found in the human butyrylcholinesterase gene. Clin Chim Acta 2002 : 326 : 193 199.
8. Bauld HW, Gibson PF, Jebson PJ, Brown SS. Aetiology of prolonged apnoea after suxamethonium. Br J Anaesth 1974 : 46 : 273 281.
9. Levano S, Ginz H, Siegemund M, et al. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine. Anesthesiology 2005 : 102 : 531 535.
10. Gatke MR, Viby-Mogensen J, Ostergaard D, Bundgaard JR. Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene. Anesthesiology 2005 : 102 : 503 508.
11. Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers. Can J Biochem Physiol 1957 : 35 : 339 346.
12. Harris H, Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes. Nature 1961 : 191 : 496 498.
13. La Du BN, Bartels CF, Nogueira CP, Arpagaus M, Lockridge O. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol Neurobiol 1991 : 11 : 79 89.
14. Bartels CF, James K, La Du BN. DNA mutations associated with the human butyrylcholinesterase J-variant. Am J Hum Genet 1992 : 50 : 1104 1114.
15. McGuire MC, Nogueira CP, Bartels CF, et al. Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci USA 1989 : 86 : 953 957.
16. La Du BN, Bartels CF, Nogueira CP, et al. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin Biochem 1990 : 23 : 423 431.
17. Maekawa M, Sudo K, Dey DC, et al. Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan. Clin Chem 1997 : 43 : 924 929.
18. Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin Chem 2003 : 49 : 1297 1308.
19. Rubinstein HM, Dietz AA, Lubrano T. E1k, another quantitative variant at cholinesterase locus 1. J Med Genet 1978 : 15 : 27 29.
20. Evans DB, Lehmann H. Pseudocholinesterase activity in liver transplantation. Lancet 1971 : 1 : 1040 1044.
21. Ison MG, Hayden FG. Viral infections in immunocompromised patients: What's new with respiratory viruses? Curr Opin Infect Dis 2002 : 15 : 355 367.